checkpoint inhibitors for metastatic urothelial cancer
Published 3 years ago • 20 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
4:11
what's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
-
0:57
how do we select the urothelial carcinoma patients who will benefit from checkpoint inhibitors?
-
2:57
immune-checkpoint inhibitors for urothelial cancer
-
5:33
cancer immune checkpoint inhibitors
-
2:01
immune checkpoint inhibitors in urothelial bladder cancer
-
1:56
immune checkpoint inhibitors for urothelial carcinoma: the current landscape
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
2:57
when can checkpoint inhibitors be used to treat urothelial carcinoma?
-
1:44
immune checkpoint inhibitors in mcrpc
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
1:10
the difficulties in treating bladder cancer with immunotherapy
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
0:50
cancer breakthrough! immune checkpoint inhibitor
-
2:01
using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
1:09
futibatinib plus pembrolizumab for the treatment of advanced or metastatic urothelial carcinoma
-
1:17
recent treatment approvals for metastatic and advanced urothelial carcinoma
-
2:31
key immunotherapy combinations for urothelial cancer
-
2:04
areas of unmet need in metastatic urothelial carcinoma